AMARYL MSR 2/500MG TAB

Amaryl MSR 2/500mg combines glimepiride and metformin in an extended-release formulation designed for type 2 diabetes management. Glimepiride stimulates insulin secretion from pancreatic beta cells, while metformin reduces hepatic glucose production and improves insulin sensitivity. This dual-action approach helps achieve better glycemic control when monotherapy proves insufficient. The modified-release technology ensures sustained drug delivery throughout the day, supporting consistent blood sugar regulation. Suitable for patients requiring combination therapy to optimize diabetes management alongside diet and exercise modifications.